Article Details
Retrieved on: 2024-10-15 22:17:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Medtronic's FDA-approved early feasibility trial for its Affera system and Sphere-9 catheter. This MedTech innovation aims to improve ventricular tachycardia treatment using pulsed field and radiofrequency ablation technologies, enhancing cardiac electrophysiology procedures.
Article found on: www.medtechdive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here